Search results
Author(s):
Vineet Agrawal
,
Kelly A Costopoulos
,
Mohammed Chowdhary
,
et al
Added:
2 years ago
Author(s):
Yang Yang
,
Aniket S Rali
,
Christian Inchaustegui
,
et al
Added:
3 years ago
Dear Editor,
The use of extracorporeal membrane oxygenation (ECMO) as salvage therapy in the most severe cases of acute respiratory distress syndrome (ARDS) has been associated with reduced mortality, particularly at high-volume centres. We report a case series of seven patients with coronavirus disease 2019 (COVID-19)-associated ARDS treated with ECMO.
In select COVID-19 patients suffering…
View more
Author(s):
Ersilia M DeFilippis
,
Veli K Topkara
,
Ajay J Kirtane
,
et al
Added:
1 year ago
Christian Inchaustegui
Research Area(s) / Expertise:
Author
Expertise
Author(s):
Federica Jiritano
,
Valeria Lo Coco
,
Matteo Matteucci
,
et al
Added:
3 years ago
Cardiogenic shock (CS) is a circulatory failure as a consequence of left, right or biventricular dysfunction.1 It leads to critical end-organ hypoperfusion due to primary cardiac dysfunction.1 Therefore, CS is not only a cardiac disease but also a multiorgan dysfunction syndrome involving the entire circulatory system, often complicated by a systemic inflammatory response syndrome.2 The goals of…
View more
Author(s):
Petr Ostadal
,
Saahil A Jumkhawala
Added:
1 year ago
AHA 22 - CardioNerds Fellow, Dr Saahil A Jumkhawala (Rutgers New Jersey Medical School, US) is joined by investigator, Dr Petr Ostadal (Na Homolce Hospital, CZ) to talk about the ECMO-CS trial (NCT02301819).
In the ECMO-CS trial 122 patients with rapidly deteriorating or severe cardiogenic shock were randomized to receive veno-arterial extracorporeal membrane oxygenation (ECMO) or early…
View more
Federico Pappalardo
Author
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
In this dynamic late-breaking science preview Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) share their take on the most anticipated trials of the AHA Scientific Sessions.
What late-breaking trials should we look out for? Which results are likely to impact your practice? What are the considerations and challenges?
Trials covered in detail include:
37s:…
View more
Author(s):
Harriette Van Spall
,
Holger Thiele
Added:
7 months ago
ESC 2023 – Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Prof Holger Thiele (Heart Center Leipzig at University of Leipzig, DE) to discuss the findings from the ECLS-SHOCK trial (NCT03637205).
The leading cause of death in hospitalised patients with acute myocardial infarction is cardiogenic shock. Efforts to improve outcomes for these patients has led to…
View more
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
7 months ago
What is hot at ESC 2023?
In this episode of View of the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, NL) preview the hot line and late-breaking data presented at ESC Congress 2023.
With their dynamic analysis, they place these highly anticipated trials within a context, highlighting the real-world implications tied to the data releases.
Top trials…
View more